Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04253457Phase 3Terminated
Phase 3, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in carpal tunnel syndrome (CTS), De Quervain tenosynovitis and trigger finger (2 arms), sponsored by University Hospitals Plymouth. Primary endpoint: Pain visual analog scale scores at 1 hour. Started Feb 2020; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04253457.